XNCR Q3 2020 Earnings — Xencor, Inc. Revenue & Financial Results | Market Cap Arena

XNCRXencor, Inc.

$861M

Q3 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$35M+62.5% YoY

Gross Profit

-$9M-25.7% margin

Operating Income

-$17M-47.3% margin

Net Income

-$13M-35.5% margin

EPS (Diluted)

$-0.22

QoQ Revenue Growth

+170.2%

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$9M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$646M

Total Liabilities

$78M

Stockholders' Equity

$568M

Cash & Equivalents

$58M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$35M	$22M	+62.5%
Gross Profit	-$9M	-$8M	-13.4%
Operating Income	-$17M	-$14M	-17.1%
Net Income	-$13M	-$10M	-22.8%

Revenue Segments

Milestone

$25M71%

License

$5M14%

Royalty

$5M13%

Collaboration

$900,0003%